tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Optimistic Buy Rating for Capricor Therapeutics Driven by Regulatory Progress and Strategic Positioning
PremiumRatingsOptimistic Buy Rating for Capricor Therapeutics Driven by Regulatory Progress and Strategic Positioning
9d ago
Capricor approval on track for mid-2026, says JonesResearch
Premium
The Fly
Capricor approval on track for mid-2026, says JonesResearch
9d ago
Unusually active option classes on open September 25th
Premium
The Fly
Unusually active option classes on open September 25th
9d ago
Capricor Therapeutics files $300M mixed securities shelf
PremiumThe FlyCapricor Therapeutics files $300M mixed securities shelf
24d ago
Capricor Therapeutics responds to FDA posting of dermiocel CRL
Premium
The Fly
Capricor Therapeutics responds to FDA posting of dermiocel CRL
25d ago
CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
Premium
Market News
CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
1M ago
Capricor Therapeutics: Strong Financial Position and Strategic Initiatives Drive Buy Rating Despite Regulatory Challenges
PremiumRatingsCapricor Therapeutics: Strong Financial Position and Strategic Initiatives Drive Buy Rating Despite Regulatory Challenges
2M ago
Capricor Therapeutics: Q2 2025 Financial and Strategic Update
Premium
Company Announcements
Capricor Therapeutics: Q2 2025 Financial and Strategic Update
2M ago
Capricor Therapeutics reports Q2 EPS (57c), consensus (48c)
Premium
The Fly
Capricor Therapeutics reports Q2 EPS (57c), consensus (48c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100